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Abstract
Background: Methylation of residues in histone tails is part of a network that regulates gene expression. JmjC domain
containing proteins catalyze the oxidative removal of methyl groups on histone lysine residues. Here, we report studies to
test the involvement of Jumonji domain-containing protein 6 (Jmjd6) in histone lysine demethylation. Jmjd6 has recently
been shown to hydroxylate RNA splicing factors and is known to be essential for the differentiation of multiple tissues and
cells during embryogenesis. However, there have been conflicting reports as to whether Jmjd6 is a histone-modifying
enzyme.
Methodology/Principal Findings: Immunolocalization studies reveal that Jmjd6 is distributed throughout the nucleoplasm
outside of regions containing heterochromatic DNA, with occasional localization in nucleoli. During mitosis, Jmjd6 is
excluded from the nucleus and reappears in the telophase of the cell cycle. Western blot analyses confirmed that Jmjd6
forms homo-multimers of different molecular weights in the nucleus and cytoplasm. A comparison of mono-, di-, and tri-
methylation states of H3K4, H3K9, H3K27, H3K36, and H4K20 histone residues in wildtype and Jmjd6-knockout cells indicate
that Jmjd6 is not involved in the demethylation of these histone lysine residues. This is further supported by overexpression
of enzymatically active and inactive forms of Jmjd6 and subsequent analysis of histone methylation patterns by
immunocytochemistry and western blot analysis. Finally, treatment of cells with RNase A and DNase I indicate that Jmjd6
may preferentially associate with RNA/RNA complexes and less likely with chromatin.
Conclusions/Significance: Taken together, our results provide further evidence that Jmjd6 is unlikely to be involved in
histone lysine demethylation. We confirmed that Jmjd6 forms multimers and showed that nuclear localization of the protein
involves association with a nucleic acid matrix.
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Introduction
Covalent histone modifications play an important role in
regulating chromatin structure, gene expression and epigenetic
inheritance [1,2]. Identified modifications of N-terminal histone
tails include phosphorylation, acetylation, ubiquitination and
methylation that provide a mechanism for fine-tuned access of
the transcriptional machinery to DNA [3]. The various combina-
tions of the histone modifications and the different outcomes on
chromatin states, gene expression and consequently on cellular
differentiation and development have been collectively referred to
as the histone code [4,5]. The methylation of histone tails is a
modification that regulates important processes such as hetero-
chromatin formation, X-chromosome inactivation, imprinting and
DNA repair [6]. This posttranslational modification can occur on
either lysine or arginine residues in the tails of histones 2, 3, and 4,
with lysines being either mono-, di-, or tri-methylated and
arginines being mono-methylated or symmetrically or asymmet-
rically di-methylated [7]. Histone lysine (K) methylation on H3K4,
H3K9, H3K27, H3K36, H3K79, and H4K20 has different
biological effects. In general [3,8], methylation on H3K4, H3K36,
and H3K79 has an activating effect on gene expression [6,9],
whereas methylation of H3K9, H3K27, and H4K20 impose a
repressing effect on transcription [10–13].
Until recently, histone methylation was thought to be
irreversible. Two types of enzymatic mechanisms for the reversal
of histone methylation marks have now been identified. The first
histone demethylase identified was the nuclear amine oxidase
KDM1 (LSD1), which catalyzes demethylation of H3K4 and
H3K9 by employing a flavin dependent reaction [14–16].
Members of the Jumonji C (JmjC) domain containing proteins
have emerged subsequently and form a second, and apparently
larger, family of histone lysyl demethylases [17–19]. The JmjC
domain of these enzymes contains a double stranded b-helix (or
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jelly roll) fold which forms a core structure that includes residues
that coordinates the Fe(II) and the co-substrate 2-oxoglutarate
(2OG). The JmjC demethylases catalyze removal of methyl groups
on lysine side chains through an oxidative hydroxylation reaction.
The JmjC enzymes are a sub-family of the 2-oxoglutarate and
Fe(II) dependent oxygenase superfamily. Bioinformatic analyses
suggest that some 2OG oxygenases are highly conserved
throughout evolution and many members of this enzyme family
can be identified in all living phyla [18,20,21]. To date, JmjC-
domain-containing histone demethylases (JHDMs [18]) have been
characterized that are capable of catalyzing the removal of all
methylation states of H3K4, H3K9, H3K36 and H3K27. JHDMs
that can demethylate H4K20 and H3K79 have not been
identified.
We have been interested in the function of the Jumonji domain
containing gene 6 (Jmjd6) [20,22,23]. Jmjd6 has been reported to be
capable to mediate demethylation of histone 3 arginine 2 (H3R2)
and demethylation of histone H4 at arginine 3 (H4R3) [24].
Recently, we have shown that Jmjd6 catalyses the oxidative
hydroxylation of the splicing factor U2 small nuclear ribonucleo-
protein auxiliary factor 65-kilodalton subunit (U2AF65) and of
Luc7-like 2 (LUC7L2) and thereby influences alternative splicing
[25]. In contrast to the prior report [24], we did not detect
arginine demethylase activity for Jmjd6 [25]. Gene ablation studies
of Jmjd6 in mice and zebrafish have demonstrated its essential role
in cell differentiation and development [22,26–28]. Jmjd6
knockout mice die around birth due to severe cardiopulmonary
malformations. These include ventral septal defects, the formation
of a double-outlet right ventricle, and hypoplasia of the pulmonary
artery that resemble the human congenital syndrome Tetralogy of
Fallot [23]. In addition, eye development is severely disturbed in
Jmjd6-deficient mice ranging from mild retinal defects to ectopic
induction of rudimental eye anlagen in nasal cavities [22,28].
Head, brain and craniofacial dysmorphisms point to defects in the
establishment of body plan symmetry [22,28]. Beside these
malformations, differentiation defects are found in the kidney,
intestine, liver and lungs during different stages of embryogenesis
[22,27,28]. Finally, fetal liver derived macrophages differentiated
from Jmjd6 knockout embryos are impaired in the release of pro-
and anti-inflammatory cytokines upon stimulation with LPS [22].
Considering the conflicting reports on the biochemical and cellular
roles of Jmjd6, the wide ranging defects observed upon Jmjd6
inactivation in multiple tissues and cells, and the role of other JmjC
domain containing proteins in regulating histone methylation, we
analyzed if Jmjd6 functions as a JmjC-domain containing histone
lysine demethylase.
Using a novel monoclonal antibody for Jmjd6, we investigated
its nuclear localization and distribution under various cell culture
and growth conditions in different human cell lines and primary
mouse embryonic fibroblasts (MEFs). Jmjd6 was found to be
located in the nucleoplasma outside of regions containing
heterochromatic DNA. This intracellular location was stable and
prominent during the interphase of the cell cycle. However, during
mitosis Jmjd6 disappears from the nucleus and condensates again
in the characteristic fine dotted nuclear pattern of the interphase
during the late anaphase and telophase of the cell cycle.
Occasionally Jmjd6 was observed in nucleoli indicating that it
may be capable of shuttling in and out of this nuclear
compartment. Using western blot analysis and immunofluores-
cence imaging, we compared histone methylation statuses in Jmjd6
wildtype and knockout cells as well as under Jmjd6 overexpressing
conditions. We report that Jmjd6 is not involved in lysine
demethylation of H3K4, H3K9, H3K27, H3K36, and H4K20
residues. Instead, we provide evidence that Jmjd6 may preferen-
tially be associated with RNA/RNA complexes which further
supports its proposed role in the regulation of RNA splicing.
Results
Analysis of intracellular Jmjd6 localization using specific
antibodies
Several anti-Jmjd6 antibodies are commercially available,
however, only one antibody has been validated before in a
wildtype/Jmjd6 knockout context [29]. Initially, we analyzed a set
of different anti-Jmjd6 antibodies using western blot analysis.
From five anti-Jmjd6 antibodies tested we found two (AB-10526
and AB-11632), which yielded reasonably specific and low
background signals when compared on lysates prepared from
Jmjd6 2/2 and Jmjd6 +/+ embryonic fibroblast cells (Figure S1 and
Figure 1). The antibody AB-11632 recognized two fragments of
50 kDa and 55 kDa that are approximately at the calculated size
of the mouse Jmjd6 protein (47 kDa), while antibody AB-10562
recognized several fragments of different molecular weights, with
four fragments of approximately 50, 100, 150 and 250 kDa being
specific for the Jmjd6 protein based on a judgment of staining
patterns in Jmjd6 2/2 and Jmjd6 +/+ cells (Figure S1 and Figure 1).
Previously, western blot and tandem-mass spectrometry analysis
have demonstrated that Jmjd6 forms high-molecular weight
multimers in the nucleus [29]. To generate a basis for further
characterization of Jmjd6 expression, we mapped the binding
epitopes of the antibodies AB-10562 and AB-11632. A peptide
‘‘spot-membrane’’ array covering the full-length Jmjd6 protein in
15-mers shifted by three amino acids was generated and
hybridized with AB-10562 and AB-11632. The peptide array
work revealed that AB-11632 binds to a linear epitope covering
amino acids 22–30 at the N-terminal part of the Jmjd6 protein,
while AB-10526 recognizes an epitope at the C-terminus covering
amino acids 364–372 (Figure S2).
Because of the difficulties experienced with commercially
available antibodies in Jmjd6 detection, we decided to generate
a monoclonal antibody specifically for this purpose. Mice were
Figure 1. Jmjd6 can be found in multimers in the nucleus and
cytoplasm. Western blot showing Jmjd6 protein as detected using
antibody AB-10526. Lanes correspond alternating to wildtype (+/+) and
Jmjd6 knockout (2/2) MEF cellular extracts. Total cell extract as well as
cytosolic and nuclear extracts have been used (from left to right,
respectively). Red arrowheads indicate bands that correspond to Jmjd6.
doi:10.1371/journal.pone.0013769.g001
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immunized with a recombinant human JMJD6 and 384
hybridoma clones were characterized using cell culture superna-
tants for immunofluorescence staining of wildtype and Jmjd6
knockout MEFs. Two out of the 384 selected hybridoma clones
showed a differential staining of Jmjd6 +/+ and Jmjd6 2/2 cells.
These were then further developed using two steps of subcloning,
which finally led to the subclone mAB328C6D11 (mAB328) that
shows a high specificity for Jmjd6 staining (Figure 2A). The
mAB328-staining pattern demonstrated again a nuclear localiza-
tion of Jmjd6 as previously reported [29–33], but it also allowed us
to characterize the nuclear distribution of the native Jmjd6 protein
in greater detail. In interphase MEFs, Jmjd6 shows a discrete
punctual immunofluorescence pattern and is not found in regions
of heterochromatic DNA organization as revealed by Hoechst
DNA staining (Figure 2B). A similar staining pattern was found in
human HEK 293-T cells and in the human lung carcinoma cell
line A549 (Figure S3A). Testing mAB328 under denaturizing
conditions in western blots and on the spot-membrane showed
that this antibody does not detect a linear epitope as no signal
could be obtained under various different hybridization conditions
(data not shown).
The distribution of Jmjd6 was found to change throughout the
cell cycle (Figure 2C). As soon as the nuclear membrane dissolves
during mitosis, Jmjd6 is no longer detected by immunocytochem-
istry. During interphase, Jmjd6 is distributed in point-shaped
clusters in the nucleoplasm as described above. In the prophase
Jmjd6 localizes to areas of uncondensed DNA. In the telophase,
Jmjd6 staining shows a diffuse pattern with no correlation to DNA
Figure 2. Characterization of Jmjd6 cellular localization using immunocytochemistry and antibody mAB328. (A) Immunofluorescence
validation of the monoclonal anti-Jmjd6 antibody mAB328. The top row shows immunofluorescence imaging of wildtype, the bottom row of Jmjd6
knockout mouse embryonic fibroblasts (MEFs). Cells were imaged in phase contrast, with Hoechst DNA stain, and stained using anti-Jmjd6 mAB328
(from left to right, respectively). (B) Magnification (100x) of a wildtype MEF nucleus stained with anti-Jmjd6 mAB328. The top image shows wildtype
MEF nuclei stained with Hoechst DNA stain (blue), the bottom shows the corresponding nuclei stained for Jmjd6 using mAB328 (green). Red
arrowheads exemplify the position of heterochromatic foci. (C) Jmjd6 distribution during the cell cycle. Rows show immunofluorescence imaging of
stained DNA (blue) and Jmjd6 (green) as well as phase contrast imaging of wildtype MEFs (from top to bottom, respectively). Vertically aligned
images correspond to the six cell cycle stages interphase, prophase, prometaphase, metaphase, anaphase, and telophase (from left to right,
respectively). The blue line at the bottom indicates the nuclear envelope integrity during the cell cycle.
doi:10.1371/journal.pone.0013769.g002
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(Figure 2C). Arresting cells in the G0-phase using serum starvation
or contact inhibition led to a weak and diffuse staining of Jmjd6
(data not shown). After release from G0-arrest, it took 72 h of slow
pattern condensation to restore the interphase-staining pattern of
Jmjd6 seen before blocking (Figure S3B). Importantly, during
these experiments some A549 cells showed a different Jmjd6
distribution pattern as indicated by red arrows in Figure S3B. In
these cases, higher magnification revealed a localization of Jmjd6
in small spheres (Figure 3A). Counterstaining with Hoechst dye
and comparison to reference images in the Nuclear Protein
Database (NPD) [34], implied a nucleolar localization. Staining
MEFs with a pan histone H3 antibody as a counter stain showed
Figure 3. Nucleolar localization and shuttling of Jmjd6. (A) Confocal immunofluorescence image of A549 cells with deviant intranuclear
distribution of Jmjd6 as compared to its interphase nucleoplasma localization. Horizontal rows show Hoechst DNA stain (blue), Jmjd6 localization
(green) and a merge thereof (from top to bottom, respectively). (B) Magnification (100x) of wildtype MEF nuclei showing intranuclear Jmjd6 shuttling.
Two horizontal rows show immunofluorescence imaging of wildtype MEF nuclei. Images correspond to Hoechst DNA stain (blue), tri-methylated
Histone H3 Lysine 36 (H3K36tri, red), Jmjd6 (green), and a merge thereof (from left to right, respectively). Red arrowheads exemplify the position of
some nucleoli as indicated by H3K36tri contra-staining.
doi:10.1371/journal.pone.0013769.g003
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that different amounts of Jmjd6 were present in nucleoli. In
exceptional cases, either nearly all visible Jmjd6 was found in the
nucleoli, or the nucleoli were completely devoid of Jmjd6
(Figure 3B). Other nucleoli staining patterns showed intermediate
amounts of Jmjd6 in between these two extremes. This indicates
that Jmjd6 is capable of shuttling in and out of nucleoli; the factors
regulating this shuttling are unknown.
Characterization of Jmjd6 cellular expression using
deletion constructs
Western blots using antibody AB-10526 on cellular fractions of
Jmjd6 +/+ and Jmjd6 2/2 MEFs confirmed that Jmjd6 (predicted
size of ,47 kDa) is a nuclear protein (Figure 1). Furthermore, as
reported, two Jmjd6 polypeptides of ,50 kDa and ,55 kDa can
be identified only in nuclear fractions [29]. These have been
suggested to result from unknown protein modification, possibly
involving proteolytic processing of Jmjd6 in the nucleus [29]. In
addition, three fragments, at ,100 kDa, ,150 kDa, and
,250 kDa, were observed that further support the previous
finding by Tibrewal et al. that Jmjd6 forms homomeric protein
complexes in nuclei [29]. These high molecular weight fragments
are likely specific for Jmjd6 because they are absent in Jmjd6 2/2
cells and that they can be found in nuclear and cytosolic cell
extracts (Figure 1). Whether the cytosolic complexes in Figure 1
are targeted for proteosomal degradation or serve biological
functions remains unclear at this stage.
In addition to its single double-stranded b-helix domain, Jmjd6
contains a poly-serine stretch and five potential nuclear localiza-
tion sites (NLS) [31]. Furthermore, an AT-hook [30], a
sumoylation site and a nuclear export signal (NES) have been
predicted [20]. To analyze the cellular expression of Jmjd6 in
more detail, we developed several Jmjd6 deletion constructs,
which were fused C-terminal to yellow fluorescent protein (YFP)
(Figure 4). Beside the full-length protein (F1/R5), three out of the
eight constructs contain the N-terminus and are truncated either
before the JmjC domain (F1/R1, residues 1 to 126), in the JmjC
domain (F1/R3, residues 1 to 288) or immediately after it (F1/R4,
residues 1 to 306). One construct contains only the JmjC domain
(F2/R4, residues 141 to 291), one contains the complete JmjC
domain in addition to the C terminus (F2/R5, residues 141 to
403), and one encompasses the last part of the JmjC domain and
the C-terminus of the protein (F3/R5, residues 266 to 403).
Finally, construct F5/R5 (residues 306 to 403) contains only the C-
terminal part of Jmjd6. The constructs were transfected in HEK
293-T cells and analyzed using fluorescent microscopy (Figure 5).
Fusions constructs containing only the JmjC domain (F2/R4) were
not detected in cells. Jmjd6 fusion constructs F1/R1, F2/R5, and
F3/R5 yielded lower transfection rates in HEK 293-T cells as
compared to the other Jmjd6 reporter constructs and the few
transfected cells displayed a bright, punctuated expression pattern
in proximity to the nucleus. This suggested that these Jmjd6-YFP
fusion proteins are probably misexpressed in cytoplasmatic
inclusions [35] and are not stable in transfected cells. YFP-fusions
containing segments F1/R3, F1/R4, F1/R5, and F5/R5 showed
normal localization to the nucleus; comparable to the staining
pattern that we observed with the antibody mAB328 (Figure 5).
To further analyze the expression of the Jmjd6-YFP fusion
constructs we performed western blot analysis on nuclear extracts
of transfected HEK 293-T cells by using the antibodies AB-11632
and AB-10526, which recognize N- and C-terminal epitopes in
Jmjd6, respectively. For detection of YFP fusion tags the anti-
green fluorescent protein (GFP) antibody AB-290 was used
(Figure 6). Immunoblotting with the anti-GFP antibody revealed
expression of the fusion proteins containing the Jmjd6 segments
F1/R3, F1/R4, F1/R5, and F5/R5 at the expected fragment sizes
(Figure 4 and Figure 6A), demonstrating that these are expressed
as monomeric Jmjd6-YFP fusion proteins. A fragment of about
60 kDa was detected in all HEK 293-T cells, including
Figure 4. Schematic representation of Jmjd6-YFP deletion constructs. Domains and motifs of the Jmjd6 protein are shown according to the
symbols displayed below. The name of each Jmjd6-YFP deletion construct and calculated size when fused to yellow fluorescence protein
(YFP, 27 kDa) is indicated on the right side. The scale indicates length of polypeptides in amino acids (aa).
doi:10.1371/journal.pone.0013769.g004
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untransfected and YFP-reporter only expressing controls
(Figure 6A), indicating that this fragment is unrelated to YFP
expression and is recognized by AB-290 non-specifically. Interest-
ingly, only in HEK cells transfected with the full-length fusion
protein Jmjd6-(F1/R5)-YFP the antibody AB-290 detected
expression of a fragment of about 150 kDa (Figure 6A, arrow).
This 150 kDa fragment is expressed at lower levels as compared to
the prominent expression of the 74.2 kDa full-length Jmjd6-
(F1/R5)-YFP fusion protein. The fragment size of ,150 kDa
suggests that this fragment is most probably a dimer of the Jmjd6-
(F1/R5)-YFP fusion protein. Indeed, immunoblotting with the C-
terminal epitope recognizing antibody AB-10526 showed expres-
sion of a corresponding ,150 kDa fragment only in Jmjd6-(F1/
R5)-YFP transfected cells (Figure 6B, arrow). Besides this
Figure 5. Immunofluorescence imaging of full-length Jmjd6 and deletion constructs fused to YFP. Fluorescent microscopy of Jmjd6-YFP
protein fusion constructs transfected into HEK 293-T cells. Horizontal rows correspond to one fusion protein and show localization of Hoechst DNA
stain (blue), Jmjd6 (red, stained with mAB328) and Jmjd6-YFP fusion protein as well as a merge thereof (from left to right). Names of Jmjd6-YFP
deletion constructs are given in brackets on the right.
doi:10.1371/journal.pone.0013769.g005
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,150 kDa fragment two other fragments of about ,100 kDa and
,130 kDA were detected with antibody AB-10526 in all
transfected and untransfected HEK cells that are probably
representing the endogenous, untagged Jmjd6 dimer (,100 kDa)
and a Jmjd6 unspecific fragment of about 130 kDA that is also
present in Jmjd6-deficient cells (Figure 1). Both of these fragments
were also detectable with antibody AB-10526 on westernblots of
MEFs isolated from Jmjd6 wildtype and Jmjd6 knockout cells
(Figure 1). This suggests that in contrast to all other Jmjd6-YFP
fusion proteins only the full-length Jmjd6-(F1/R5)-YFP fusion
protein is capable of oligomerisation and dimer formation in
transfected cells. A corresponding fragment of ,150 kDa was not
detected with the N-terminal epitope recognizing antibody
AB11632, suggesting that the epitiope recognized by this antibody
is not available for binding in a Jmjd6 dimer (Figure 6C). This is in
line with our westernblot results on Jmjd6 wildtype and Jmjd6
knockout cells (Figure 1 and Figure S1). Jmjd6-specific high
molecular weight fragments indicative of homomultimer forma-
tion are only detected with the C-terminal epitope-recognizing
antibody AB10526 and not with the N-terminal epitope binding-
antibody AB11632, further suggesting that the N-terminal region
of the protein is not available for antibody binding in Jmjd6
oligomers. The biochemical nature of Jmjd6 multimerization is
still unknown. Tibrewal et al. [29] have suggested that Jmjd6
multimers are formed by covalent cross-linking of protein
monomers. Apparently, these Jmjd6 oligomers are not dissociated
by separation in denaturating SDS-PAGE gels, however, the
underlying mechanism of Jmjd6 multimerization is complex and
warrants future investigation into its molecular nature and
biological function. Immunoblotting with all three antibodies
Figure 6. Western blot analysis of nuclear extracts prepared from Jmjd6-YFP fusion construct transfected HEK 293-T cells. YFP fusion
constructs from different Jmjd6 deletions were transfected into HEK 293-T cells and nuclear extracts were separated on a SDS-PAGE and blotted.
(A) Immunoblot with anti-GFP antibody AB-290 showing expression of Jmjd6-YFP fusion proteins and of a YFP only expressing control in transfected
HEK 293-T cells. (B) Immunoblot with anti-Jmjd6 antibody AB-10526 showing expression of Jmjd6-YFP fusion proteins containing the C-terminus of
the Jmjd6 protein. (C) Immunoblot with antibody AB-11632 recognizing the N-terminus of Jmjd6-YFP fusion proteins. (D) Western blot with the anti-b
actin antibody AB-6276 serving as a protein loading control for the SDS-PAGE. (un = untransfected control, YFP control = cells transfected with a
YFP expressing control vector, arrows in (A) and (C) indicate expression of a ,150 kDa fragment corresponding to the size of a Jmjd6-(F1/R5)-YFP
dimer).
doi:10.1371/journal.pone.0013769.g006
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revealed no expression of Jmjd6-YFP fusion constructs F1/R1,
F2/R4, F2/R5, and F3/R5, demonstrating in line with our
fluorescent microscopy analysis (Figure 5) that these truncated
Jmjd6 proteins are unstable and possibly proteolytically degraded
in transfected cells.
Jmjd6 is not involved in histone lysine demethylation
Recently, studies have identified JmjC-domain containing
proteins as histone demethylases that antagonize different
methylation states at histone lysine residues H3K4, H3K9,
H3K27, H3K36, and H4K20 [19,36–51]. To test if Jmjd6 might
be involved in the demethylation of these histone lysine residues,
we compared mono- (me1), di- (me2), and tri-(me3) methylation
states of H3K4, H3K9, H3K27, H3K36, and H4K20 in MEFs
generated from wildtype and Jmjd6 knockout mice. No differences
in methylation states between Jmjd6 +/+ and Jmjd6 2/2MEFs were
detected when these histone residues were analyzed using western
blots of cellular lysates and specific antibodies (Figure 7A).
It is established that the Hx[D/E]xnH-motif which forms a triad
of iron binding residues in the JmjC domain containing proteins is
essential for the enzymatic activity of almost all of these proteins
[52]. To ensure complete loss of activity [53], we generated Jmjd6-
(AxA)-Halo, a Jmjd6 fusion protein variant in which the first
histidine and aspartic acid of the catalytical triad are mutated to
alanines, thus rendering the JmjC domain of Jmjd6 enzymatically
inactive. When overexpressing Jmjd6-Halo or Jmjd6-(AxA)-Halo
in HEK 293-T cells, no difference in the amount of methylation of
H3K4, H3K9, H3K27, H3K36, and H4K20 between untrans-
fected cells and those overexpressing the different Jmjd6 variants
could be detected (Figure 7B). Finally, to verify these findings,
single cell analysis was performed on Jmjd6-Halo transfected cells
using immunofluorescent imaging. Differences in histone methyl-
ation patterns were not detected in cells overexpressing Jmjd6-
Halo in comparison to non-transfected controls (Figure 8 and
Figures S4, S5 and S6). In addition, histone methylation
dependent patterns did not differ in wildtype and Jmjd6 knockout
MEFs when these histone residues were analyzed by immunocy-
tochemistry (Figure 8 and Figures S4, S5 and S6). Taken together,
these results demonstrate that Jmjd6 is very likely not directly
involved either in mono-, di-, or tri-demethylation of histone lysine
residues H3K4, H3K9, H3K27, H3K36, or H4K20.
Jmjd6 is associated with RNA in cell nuclei
Cikala and colleagues proposed that Jmjd6 might possess an
AT-hook DNA binding domain just C-terminal of the JmjC
domain, which might allow binding of the protein to DNA [30]
though structural predictions suggest maintaining a functional
AT-hook whilst maintaining catalytic function is unlikely. To
investigate this hypothesis, we treated MEFs (Figure 9) and HEK
293-T cells with Triton X-100 and with DNase I and RNase A
and used mAB328 for Jmjd6 immunofluorescence staining.
Treating cells only with Triton X-100 before fixation did not
show any effect on Jmjd6 nuclear staining pattern. This
observation implies that Jmjd6 is not a highly mobile protein,
possibly because it is associated with some kind of nuclear matrix
or complex, which prevents the protein from being washed out of
perforated cells. Incubation of cells with Triton X-100 and DNase
I before fixation and mAB328-staining removed Jmjd6 and DNA
completely, indicating that this matrix has an important effect on
Jmjd6 localization. To investigate a possible association of Jmjd6
with RNA, we performed a combination of Triton X-100 and
RNase A incubation before fixation. This resulted in a complete
removal of Jmjd6 from the cells but left the DNA intact. This
indicates that Jmjd6 might be associated with RNA and/or RNA
complexes and is washed out of cells as soon as the nuclear matrix
is lost, e.g. by DNA degradation.
Discussion
We have investigated the expression of Jmjd6 in nuclear
compartments and analyzed regions of the protein required for its
nuclear expression. We also tested for a possible role of Jmjd6 in
histone lysine demethylation and analyzed a potential association
of the protein with nucleic acid/nucleic acid complexes.
The key findings of our work are as follows. First, we show that
the endogenous Jmjd6 protein is located in punctuated clusters in
the nucleoplasm of human and mouse cells during the interphase
Figure 7. Loss or overexpression of Jmjd6 does not cause changes in H3K4, H3K9, H3K27, H3K36 and H4K20 histone methylation.
(A) Immunoblot analysis of Jmjd6 wildtype and knockout MEFs for differences in histone lysine methylation. All experiments were performed
analyzing the mono- (Me1), di- (Me2), or tri-methylated (Me3) forms of histones H3K4, H3K9, H3K27, H3K36, and H4K20 using appropriate antibodies
against the modification state of methylated histones. The empty Halo-Tag vector served as control for the expression of Jmjd6-Halo fusion proteins.
All lanes contain the same amount of protein and are from the same sample. beta-actin served as a loading control for equal amounts of protein.
(B) Overexpression of wildtype Jmjd6 or of a Jmjd6 variant with an inactivated JmjC-Domain (Jmjd6-AxA-Halo) both fused to the Halo-Tag in HEK
293-T cells. All experiments were performed analyzing the mono- (Me1), di- (Me2), or tri-methylated (Me3) forms of histones H3K4, H3K9, H3K27,
H3K36, and H4K20 as shown in (A). The empty Halo-Tag vector served as control for fusion proteins. beta-actin immunoblotting is shown as a loading
control. (A) and (B) represent results from at least three independent experiments.
doi:10.1371/journal.pone.0013769.g007
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of the cell cycle. This discrete punctuated expression pattern is lost
when cells start to divide and the nuclear membrane dissolves.
During the interphase of the cell cycle Jmjd6 is occasionally
observed in nucleoli suggesting that it is capable of shuttling in and
out of nucleoli. Previously, we, and others, have reported [22,29–
33] that Jmjd6 is a nuclear protein. These results were based
primarily on transfection studies with overexpressing Jmjd6-
reporter constructs fused to protein tags because of the
unavailability of suitable antibodies for immunocytochemistry. In
this study, we investigated the expression of the endogenous Jmjd6
protein using immunocytochemistry and the novel monoclonal
antibody mAB328, which was specifically generated for this
purpose and validated for specific recognition of Jmjd6 using Jmjd6
knockout cells. Second, we show that Jmjd6 is likely not involved
in histone lysine demethylation of H3K4, H3K9, H3K27, H3K36,
and H4K20 residues, at least under natural conditions.
Nuclear expression of Jmjd6
Jmjd6 contains five potential nuclear localization signals [31]
and one recently predicted nuclear export signal [20]. Using the
monoclonal antibody mAB328 we found Jmjd6 expressed in the
nucleoplasm of interphase cells outside of regions containing
heterochromatic DNA. Interestingly, Jmjd6 was also found to be
localized in nucleoli. The attendant circumstances of this
localization could not be experimentally dissected. Different
intensities observed in Jmjd6 nucleoli staining patterns suggest
that Jmjd6 can shuttle between the nucleoplasm and these
subnuclear compartments. Nucleoli are highly dynamic structures
and the nucleolar proteome can vary to a great extend under
different metabolic and cellular growth conditions [54]. In
addition, recent studies have shown that nucleoli play a major
role in the physiological adaptation of cells to exogenous stress
such as DNA damage, heat shock or hypoxia [55–57]. Thus, it
may be that Jmjd6 is involved in the regulation of cellular stress
responses in nucleoli. Treatment of cells with RNase A and DNase
I is providing evidence that the nuclear localization of Jmjd6 is
dependent on an intact ribonuclear matrix in the nucleoplasm. As
soon as RNA is degraded, the interphase-staining patterns of
Jmjd6 is lost (Figure 9), thus implying that association with RNA
causes nuclear concentration of Jmjd6. Mechanisms underlying
these interactions of Jmjd6 with RNA remain to be established,
but may involve the binding of Jmjd6 to splicing regulatory
proteins or direct binding to RNA [25]. In fact, support for a
direct interaction of Jmjd6 with RNA has recently been published.
By using band shift assays Hong and colleagues found that Jmjd6
binds to single stranded RNA [58]. If this interactions relates to the
nuclear localisation of the protein or to its catalytic activity
remains open and will require future studies regarding its
specificity.
In line with the study by Tibrewal et al we found further
evidence for expression of Jmjd6 multimers in nuclear and
cytoplasmatic extracts (Figure 1). Westernblot analysis of HEK
293-T cells transfected with Jmjd6-YFP fusion constructs detected
expression of a fragment most likely corresponding to an YFP-
tagged dimer form of Jmjd6. The crystal structure of the Jmjd6
protein has recently been solved [58,59]. Jmjd6 possesses the
characteristic double-stranded b-helix (DSBH) fold that forms the
catalytic centre of the enzyme, which has been described for all
known 2OG oxygenase structures [58,59]. Mantri and colleagues
have demonstrated that recombinant Jmjd6 protein oligomerises
Figure 8. Immunofluorescence analysis of H3K4me1 effects caused by Jmjd6 deficiency or overexpression. The top two rows show
immunofluorescence images of Hoechst DNA stain (blue), Jmjd6 (green), and a histone lysine methylation state specific antibody (red) from wildtype
and Jmjd6-KO MEFs (from left to right, respectively). Mono-methylated H3K4 was analyzed. The bottom row shows immunofluorescence images of
Hoechst DNA stain (blue), Jmjd6 (red), and H3K4me1 (green) in Jmjd6-Halo overexpressing A549 cells (from left to right, respectively). Yellow
arrowheads indicate transfected cells. The experiments were performed three times with similar results.
doi:10.1371/journal.pone.0013769.g008
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in solution and forms a stable complex as a homodimer [59].
Elucidation of the Jmjd6 dimer crystal structure revealed a
complex interaction between two monomomers. The interface is
composed of interactions between N- and C-terminal a-helixes and
of loops between a-helixes and b-sheets of both monomers [59].
These regions of interactions are located at the N- and C-terminal
parts of both molecules and explain why we could detect
expression of a fragment corresponding to the size of a Jmjd6-
YFP dimer only in cells transfected with the full-length Jmjd6-(F1/
R5)-YFP fusion construct (Figure 6). All other truncated Jmjd6-
YFP fusion proteins were either not properly expressed in
transfected cells or lacked critical regions for intermolecular
interactions between monomers. Future studies will address if
interaction between Jmjd6 monomers in vivo are solely formed by
strong electrostatic interactions or if further posttranslational
modifications are required for covalent linkage of monomeric
molecules and Jmjd6 multimer assembly.
Jmjd6 is not a JmjC-domain containing histone lysine
demethylase
Jmjd6 was reported to be capable of catalysing demethylation of
histone 3 arginine 2 (H3R2) and of histone H4 at arginine 3
(H4R3) [24]. These data were based on assays involving in vitro
substrates and recombinant JMJD6 protein as well as on studies
Figure 9. For nuclear localization of Jmjd6 an intact ribonuclear matrix is needed.Wildtype MEFs were treated with Trition X-100, RNase A,
DNase I or a combination of Trition X-100 with RNase A or DNase I before fixation and staining. Time intervals and concentration of reagents used in
the experiments are indicated on the right side. Untreated cells were used as controls. Horizontal rows correspond from left to right to a phase
contrast view and immunofluorescence imaging of Hoechst DNA stain (blue), H3K36tri (red) and Jmjd6 (green). Shown is one representative result of
at least three experiments performed.
doi:10.1371/journal.pone.0013769.g009
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overexpressing Jmjd6-reporter fusion proteins in HeLa cells [24].
In our studies reported here, Jmjd6 was not implicated in histone
lysine demethylation of H3K4me3, H3K9me2, H4K20me2 and
of H3K36 methylated in vitro with the Set2 methyltransferase [24].
We demonstrate in this work using comparison of global
methylation states in wildtype and Jmjd6-deficient MEFs that
Jmjd6 is not involved in catalysing demethylation of mono-, di-,
and tri-methylation states of H3K4, H3K9, H3K27, H3K36, and
H4K20 in cells at least under natural conditions. This is further
confirmed by analysis of A549 and HEK 293-T cells transfected
with Halo-tagged wildtype and enzymatically inactive Jmjd6
reporter constructs using western blot analysis (Figure 7) and by
immunocytochemistry assays with antibodies suitable to detect all
histone lysine methylation states (Figure 8 and Figures S5, S6 and
S7). Although we have not tested for all possible demethylation
substrates (e.g. H3K79), together, with the results of Webby et al.
[25] on a lack of lysine demethylation, our results imply that Jmjd6
is unlikely to be involved in histone lysine demethylation.
Most recently, we identified Jmjd6 to interact with splicing
regulatory proteins and to modify some of these by posttransla-
tional hydroxylation [25]. This work also did not find evidence for
arginine demethylation activity by Jmjd6. Instead Jmjd6 was found
to catalyse lysyl-5-hydroxylation of the splicing factor U2AF65 in
vivo, and of LUC7L2 in vitro [25]. Hydroxylation of these proteins
by Jmjd6 changed alternative splicing [25]. By treating cells with
RNase we found that nuclear Jmjd6 might be preferentially
associated with RNA. However, further studies are needed to
investigate if a direct interaction of Jmjd6 with RNA in vivo is
needed for nuclear localization and function.
Materials and Methods
Chemicals, enzymes, medium and cells
Chemicals and restriction enzymes were from Sigma (St. Louis,
USA) and New England Biolabs (Ipswich, USA), respectively.
DMEM cell culture medium was from GIBCO (Carlsbad, USA),
FCS Gold foetal calf serum from PAA Laboratories (Pasching,
Austria). The human A549 (DSMZ, No. ACC 107) and HEK
293-T (DSMZ, No. ACC 305) cell lines were obtained from the
German Collection of Microorganisms and Cell Cultures (DSMZ,
Braunschweig, Germany). For preperation of nuclear cell extracts
from transfected HEK 293-T cells the NE-PER nuclear and
cytoplasmatic extraction reagents have been used together with
the Thermo Scientific Halt Protease Inhibitor Cocktail (Thermo
Scientific, Pierce Biotechnology, Rockford, USA). Standard cell
culture conditions were used for A549 and HEK 293-T cell lines,
harvesting and cell culture of mouse embryonic fibroblasts (MEFs)
was described previously [60]. Cells where either arrested in G0
through serum starvation or contact inhibition.
Expression constructs and transfection
Sequences of primers used for the cloning of Jmjd6 fusion,
reporter and deletion constructs are given in Table S1. Jmjd6-
Halo fusion constructs were obtained by cloning full-length Jmjd6
cDNA (Clone IRAV D0197p968D6, ImaGenes, Berlin, Germany)
amplified with primer pair 1 into pHT2 (Promega, Madison, USA)
using BamHI/NheI. The Jmjd6-(AxA) variant containing an
inactivated JmjC-domain was obtained by replacing the JmjC
domain and C-terminal part of Jmjd6 using the product of primer
pair 2. The forward primer contains two mutations to inactivate
the HxD motif of Jmjd6 (HID changed to AIA in the predicted
catalytical triad). The PCR product was digested with PfIMI and
XhoI and exchanged against the same fragment of Jmjd6, gaining
full-length Jmjd6-(AxA). A YFP expression vector was generated
by amplifying full-length YFP with primer pair 3 and cloning it
into pCMV-Tag1 (Stratagene, La Jolla, USA) using NheI/XhoI.
Jmjd6-YFP deletion constructs were obtained by amplifying parts
of Jmjd6 from clone IRAV D0197p968D6 using primer pairs 4 to
11 and cloning them into the YFP expression vector using
NotI/SalI. Correct reading frames of all constructs were confirmed
by sequencing before usage.
Cells and cell lines were transfected with these constructs using
Nanofectin (PAA Laboratories, Pasching, Austria) or using
FuGENE HD transfection reagent (Roche Diagnostics Ltd.,
Burgess Hill, UK) according to the manufacturers instructions.
Monoclonal antibody generation and epitope mapping
Generation of a monoclonal antibody against Jmjd6 was
performed as described [61] using human recombinant JMJD6
for immunization. Initial testing of hybridoma cells used
cultivation supernatant in immunofluorescence imaging of wild-
type and Jmjd6-knockout MEFs. Positive antibody producing cells
were further selected in two rounds of subcloning.
Epitope mapping was performed on a spot-membrane covering
Jmjd6 in fifteenmers, each shifted by three amino acids. The
membrane was blocked for 1 h in skim milk and incubated with
the primary antibody in Genosys blocking buffer (Sigma-Genosys,
St.Louis, USA) 1:10 in TBS over night according to manufactures
instructions. The membrane was washed 2620 min in TBS-T
(0,1% Tween in TBS) and incubated for 1 h with a horseradish
peroxidase (HRP) conjugated secondary antibody in Genosys
blocking buffer. After washing the membrane twice in TBS-T, it
was imaged with ECL plus (GE Healthcare Life Sciences,
Uppsala, Sweden) for chemifluorescence.
Immunofluorescence staining and imaging
Antibodies used for immunocytochemistry are listed in Table
S2. Cells growing on cover slides were washed in TBS, fixed with
4% para-formaldehyde on ice for 15 min and washed once with
TBS before blocking with block-sperm buffer (1% BSA, 0.1%
Triton X-100 in TBS) for 1 h. After washing once with TBS, cells
were incubated with the primary antibody for 1 h in antibody
buffer (1% BSA in TBS). Cells were washed three times with TBS
and incubated with the appropriate secondary antibody and
Hoechst DNA stain (1:200) in antibody buffer for 1 h. After
washing three times with TBS, cells were imaged using
fluorescence microscopy with a Zeiss Axiovert 100 microscope
using a Plan-Neofluar 100x/1.3 NA oil immersion lens. A digital
AxioCam HRc camera (Zeiss, Go¨ttingen, Germany) was used for
documentation. All experiments were performed at least in
triplicate. For histone methylation state analysis, we examined
about 150 cells in each experiment.
For RNase A or DNase I treatment, cells were incubated in
0.1% Triton X-100 for 15 sec, washed twice and incubated with
RNase A (1 mg/ml in PBS, Invitrogen) or DNase I (10 U/ml in
PBS, Roche, Indianapolis, USA) for 15 min and washed twice
with PBS prior to fixation.
Cell fractioning, immunoprecipitation and western
blotting
Cells were washed in PBS, scrapped in Lysisbuffer (10 mM
Hepes, 1,5 mM MgCl2, 10 mM KCl, 0.2% NP-40, 0.2%
2-mercaptoethanol, proteasome inhibitor, and kept on ice for
20 min. After centrifuging at 2000 g for 5 min, the cytosolic
fraction was collected as supernatant. The pellets were resus-
pended in Nucleusbuffer (20 mM Hepes, 1,5 mM MgCl2,
400 mM NaCl, 25% Glycerol, 1 mM DTT, proteasome
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inhibitor), kept on ice for 20 min and centrifuged again (2000 g for
5 min). The supernatant was collected as nuclear fraction. Nuclear
extracts were prepared from transfected HEK 293-T cells using
the NE-PER reagents from Pierce Biotechnology (Rockford, USA)
according to manufactures instructions.
SDS-Page separated samples were blotted on nylon membranes
(Immobilon, Millipore, Billerica, USA) for 25 min at 100 V using
blotting buffer (0.3% Tris, 1.44% Glycin, 20% MeOH, 0.375%
SDS. The membrane was washed in TBS-T, blocked in Western
milk (0,1% Tween in skim milk) for 1 h and incubated with the first
antibody inWestern milk over night. After washing twice with TBS-
T for 20 min, the membrane was incubated with an appropriate
HRP conjugated secondary antibody in Western milk, washed
again (2620 min in TBS-T) and imaged using ECL plus for
chemifluorescence. Experiments were performed in triplicate.
Supporting Information
Figure S1 Western blot analysis of wildtype and Jmjd6 knockout
MEFs using different anti-Jmjd6 antibodies. This panel shows
western blots with total cell lysates from wildtype and Jmjd6-KO
MEFs using four different antibodies against Jmjd6. AB-32740, AB-
28349, AB-28348, and AB-11632 were evaluated. Red arrowheads
mark bands not present in Jmjd6-knockout lanes. All lanes contain
the same amount of protein and are from the same sample. Beta-actin
served as a loading control for equal amounts of protein on the gel.
Found at: doi:10.1371/journal.pone.0013769.s001 (1.57 MB
PDF)
Figure S2 Epitope-mapping of AB-11632 and AB-10526. A spot
membrane covering the full length Jmjd6 protein in fifteenmers, each
shifted by three amino acids, was incubated with AB-11632 and AB-
10526. (A) AB-11632 binds to seven fifteenmers and six thereof show
high intensity. The core epitope covers the amino acids DWTRHN.
(B) AB-10526 binds to seven fifteenmers and five thereof show high
intensity. The core epitope covers the amino acids GDG.
Found at: doi:10.1371/journal.pone.0013769.s002 (0.07 MB
PDF)
Figure S3 Jmjd6 staining pattern in different cell lines and Jmjd6
distribution over time after releasing A549 cells from a G0-block.
(A) Comparison of Jmjd6 nuclear expression pattern between
murine MEFs and the human cell lines A549 and HEK 293-T.
Cells were stained with Hoechst DNA stain (left panel) and for
Jmjd6 using the anti-Jmjd6 mAB328 antibody (right panel). (B)
Vertical image pairs correspond to a time point 6 h, 24 h, 48 h, or
72 h after releasing A549 cells from a G0-block. The large images
show Jmjd6 distribution in green, the small insets the correspond-
ing Hoechst DNA stain in blue. Red arrowheads indicate nuclei
with deviant intranuclear Jmjd6 distribution. Shown is one
representative experiments of at least at least three performed.
Found at: doi:10.1371/journal.pone.0013769.s003 (4.22 MB
PDF)
Figure S4 Single cell analysis of H3K9 and H4K20 methylation
effects caused by Jmjd6 deficiency or overexpression. The top two
rows show immunofluorescence images of Hoechst DNA stain
(blue), Jmjd6 (green), and a histone lysine methylation state specific
antibody (red) from wildtype and Jmjd6-KO MEFs (from left to
right, respectively). The bottom row shows immunofluorescence
images of Hoechst DNA stain (blue), Jmjd6 (red), and a histone
lysine methylation state specific antibody (green) in Jmjd6-Halo
overexpressing A549 cells (from left to right, respectively). Yellow
arrowheads indicate transfected cells. Figure (A) shows results for
H3K9me1, (B) for H3K9me2, (C) for H4K20me1, and (D) for
H4K20me3. All experiments shown were performed at least at
least three times with similar results.
Found at: doi:10.1371/journal.pone.0013769.s004 (0.76 MB
PDF)
Figure S5 Immunofluorescence analysis of H3K4 and H3K36
methylation effects caused by Jmjd6 deficiency or overexpression.
The top two rows show immunofluorescence images of Hoechst
DNA stain (blue), Jmjd6 (green), and a histone lysine methylation
state specific antibody (red) from wildtype and Jmjd6-KO MEFs
(from left to right, respectively). The bottom row shows immuno-
fluorescence images of Hoechst DNA stain (blue), Jmjd6 (red), and a
histone lysine methylation state specific antibody (green) in Jmjd6-
Halo overexpressing A549 cells (from left to right, respectively).
Yellow arrowheads indicate transfected cells. Figure (A) shows
results for H3K4me1, (B) for H3K4me2, (C) for H3K4me3, (D) for
H3K36me1, (E) for H3K36me2, and (F) for H3K36me3. The
experiments were performed at least three times with similar results.
Found at: doi:10.1371/journal.pone.0013769.s005 (1.22 MB
PDF)
Figure S6 Immunofluorescence analysis of H3K27 methylation
effects caused by Jmjd6 deficiency or overexpression. The top two
rows show immunofluorescence images of Hoechst DNA stain
(blue), Jmjd6 (green), and a histone lysine methylation state specific
antibody (red) from wildtype and Jmjd6-KO MEFs (from left to
right, respectively). The bottom row shows immunofluorescence
images of Hoechst DNA stain (blue), Jmjd6 (red), and a histone
lysine methylation state specific antibody (green) in Jmjd6-Halo
overexpressing HEK 293-T cells (from left to right, respectively).
Yellow arrowheads indicate transfected cells. Figure (A) shows
results for H3K27me1, (B) for H3K27me2, and (C) for H3K27me3.
The experiments were performed three times with similar results.
Found at: doi:10.1371/journal.pone.0013769.s006 (0.85 MB
PDF)
Table S1 Primer pairs used for cloning of Jmjd6 fusion/reporter
proteins. Sequences of primers used for the cloning of Jmjd6
fusion, reporter and deletion constructs.
Found at: doi:10.1371/journal.pone.0013769.s007 (0.04 MB
PDF)
Table S2 Antibodies used in Western blotting and immunoflu-
orescence imaging. List of antibodies used for western blotting and
immunocytochemistry.
Found at: doi:10.1371/journal.pone.0013769.s008 (0.06 MB
PDF)
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